These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15548905)

  • 1. The potential effect of widespread use of pneumococcal conjugate vaccines on the practice of pediatric otolaryngology: the case of acute otitis media.
    Dagan R
    Curr Opin Otolaryngol Head Neck Surg; 2004 Dec; 12(6):488-94. PubMed ID: 15548905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    de Sévaux JL; Venekamp RP; Lutje V; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD001480. PubMed ID: 33231293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001480. PubMed ID: 31135969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?
    Dagan R
    Vaccine; 2008 Jun; 26 Suppl 2():B16-8. PubMed ID: 18793601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pneumococcal conjugate vaccines on microbial epidemiology and clinical outcomes of acute otitis media.
    Hau I; Levy C; Caeymaex L; Cohen R
    Paediatr Drugs; 2014 Feb; 16(1):1-12. PubMed ID: 23963858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current face of acute otitis media: microbiology and prevalence resulting from widespread use of heptavalent pneumococcal conjugate vaccine.
    Brunton S
    Clin Ther; 2006 Jan; 28(1):118-23. PubMed ID: 16490585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal acute otitis media in infants and children in central Romania, 2009-2011: microbiological characteristics and potential coverage by pneumococcal conjugate vaccines.
    Falup-Pecurariu O; Leibovitz E; Mercas A; Bleotu L; Zavarache C; Porat N; Dagan R; Greenberg D
    Int J Infect Dis; 2013 Sep; 17(9):e702-6. PubMed ID: 23522635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction.
    Angoulvant F; Cohen R; Doit C; Elbez A; Werner A; Béchet S; Bonacorsi S; Varon E; Levy C
    BMC Infect Dis; 2015 Jun; 15():236. PubMed ID: 26093673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county.
    Littorin N; Ahl J; Uddén F; Resman F; Riesbeck K
    BMC Infect Dis; 2016 Aug; 16(1):407. PubMed ID: 27514843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of immunization with pneumococcal conjugated vaccines on Streptococcus pneumoniae resistance patterns in acute otitis media.
    Marom T; Avraham E; Cinamon U; Tamir SO
    J Microbiol Immunol Infect; 2017 Oct; 50(5):714-717. PubMed ID: 26507672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines.
    Dagan R; Givon-Lavi N; Shkolnik L; Yagupsky P; Fraser D
    J Infect Dis; 2000 Apr; 181(4):1322-9. PubMed ID: 10753730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal conjugate vaccines for preventing otitis media.
    Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2014 Apr; (4):CD001480. PubMed ID: 24696098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance.
    Klugman KP
    Lancet Infect Dis; 2001 Sep; 1(2):85-91. PubMed ID: 11871480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in treatment strategies for acute otitis media after full implementation of the pneumococcal seven valent conjugate vaccine.
    Harrison CJ
    Pediatr Infect Dis J; 2003 Aug; 22(8 Suppl):S120-30. PubMed ID: 14566998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network.
    Kempf M; Varon E; Lepoutre A; Gravet A; Baraduc R; Brun M; Chardon H; Cremniter J; Croizé J; Dalmay F; Demachy MC; Fosse T; Grelaud C; Hadou T; Hamdad F; Koeck JL; Luce S; Mermond S; Patry I; Péchinot A; Raymond J; Ros A; Segonds C; Soullié B; Tandé D; Vergnaud M; Vernet-Garnier V; Wallet F; Gutmann L; Ploy MC; Lanotte P
    Clin Microbiol Infect; 2015 Jan; 21(1):35-42. PubMed ID: 25636925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic Resistance of Potential Otopathogens Isolated From Nasopharyngeal Flora of Children With Acute Otitis Media Before, During and After Pneumococcal Conjugate Vaccines Implementation.
    Rybak A; Levy C; Bonacorsi S; Béchet S; Vié le Sage F; Elbez A; Varon E; Cohen R
    Pediatr Infect Dis J; 2018 Mar; 37(3):e72-e78. PubMed ID: 29227464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era.
    Pichichero ME; Casey JR
    Pediatr Infect Dis J; 2007 Oct; 26(10 Suppl):S12-6. PubMed ID: 18049375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age.
    Karppinen S; Toivonen L; Schuez-Havupalo L; Teros-Jaakkola T; Waris M; Auranen K; Palmu AA; Peltola V
    Vaccine; 2019 May; 37(22):2935-2941. PubMed ID: 31027929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation.
    Cohen R; Varon E; Doit C; Schlemmer C; Romain O; Thollot F; Béchet S; Bonacorsi S; Levy C
    Vaccine; 2015 Sep; 33(39):5118-26. PubMed ID: 26271823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.